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Suppression is a common mechanism employed by viruses to evade the antiviral effects of the host’s RNA
silencing pathway. The activity of suppression has commonly been localized to gene products in the
virus, but the variety of mechanisms used in suppression by these viral proteins spans nearly the complete biochemical pathway of RNA silencing in the host. This review describes the agroﬁltration assay
and a slightly modiﬁed version of the agro-inﬁltration assay called co-inﬁltration, which are common
methods used to observe RNA silencing and identify viral silencing suppressor proteins in plants, respectively. In addition, this review will provide an overview of two methods, electrophoretic mobility shift
assay and ﬂuorescence polarization, used to assess the binding of a suppressor protein to siRNA which
has been shown to be a general mechanism to suppress RNA silencing by plant viruses.

1. Introduction
RNA silencing is a conserved biochemical pathway that results
in the sequence-speciﬁc degradation of RNA. Regulation of gene
expression associated with the degradation of RNA in the pathway
has been shown to play an important role in organism development [1] and genome integrity [2]. In addition, RNA silencing
serves as a defense mechanism in higher plants and insects when
it is triggered by dsRNA from invading viruses [3–5]. dsRNA created during viral replication and dsRNA-like molecules formed by
single-stranded viral RNAs or aberrant RNAs that fold into dsRNA
segments potentially with mismatched and/or unpaired bases are
processed in plants by the host’s Dicer-like proteins (DCLs) into viral siRNAs (21–24 nucleotides) that accumulate in the infected cells
[6–9]. These viral siRNAs are subsequently incorporated into the
host’s RNA-induced silencing complex (RISC) and one of the proteins of the complex, a member of the Argonaute (AGO) family of
proteins, guides these viral siRNAs to a complementary viral RNA
sequence and catalyzes the hydrolysis of the phosphate backbone
[10–13]. In addition to the accumulation of viral siRNAs during
the primary infection, many viral infections result in an ampliﬁcation of the silencing signal likely using viral aberrant ssRNA and the
host’s RNA-dependent RNA polymerases (RDRs) resulting in viral
dsRNAs which are processed by DCLs [14–17].
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Many viruses have evolved counter defense mechanisms that
suppress the antiviral effects of RNA silencing and these mechanisms have typically been linked to one or more proteins produced
by each virus. Viral RNA silencing suppressor proteins have been
identiﬁed in many viruses that attack hosts from each of the kingdoms, they display little to no sequence homology, and their mechanisms of suppression span the complete pathway of RNA silencing
[18,19]. Consequently, protein suppressors of RNA silencing show a
lack of conserved sequence homology across viral genera. As a result, they have been grouped into the following categories: (1)
inhibition of the binding and processing of viral dsRNA into viral
siRNA, (2) inhibition of the assembly of RISC, (3) inhibition of the
targeting of viral dsRNAs, and (4) inhibition of the ampliﬁcation
of viral siRNAs (reviewed in [18,19]). Several of the mechanisms
used by the suppressor proteins use dsRNA binding as a general
strategy of suppression [20]. Some silencing suppressors have been
shown to bind long hairpin derived or inverted repeat dsRNA and
prevent them from being processed into siRNAs [21,22], others
bind and sequester siRNAs and prevent their incorporation into
RISC [23,24], and still others have been shown to compete with
RDRs for binding dsRNA with 50 ssRNA overhangs to prevent the
ampliﬁcation of viral siRNAs [25].
This review will ﬁrst focus on one of the techniques used to
visualize RNA silencing in plants, the agroinﬁltration assay. Specifically, we will address the theory behind the procedure and provide an overview of the protocol. Second, we will provide the
theory and procedure for the agro-coinﬁltration assay that has
been used to visualize and identify RNA silencing suppression in

plants. Finally, we will provide an overview of two techniques, the
electrophoretic mobility shift assay and ﬂuorescence polarization,
used to characterize the afﬁnity and speciﬁcity of siRNA binding
by RNA silencing suppressor proteins.
2. Identiﬁcation of RNA silencing suppressor proteins
2.1. Agro-inﬁltration assay to visualize RNA silencing
RNA silencing in plants is commonly induced and visualized
using the agroinﬁltration assay in transgenic plants. This assay is
usually performed in a commonly studied plant (Arabidopsis thaliana or Nicotiana benthamiana) with a stably integrated and transiently expressed reporter gene, usually encoding Escherichia coli
b-glucuronidase (GUS) or Aequorea victoria green ﬂuorescent protein (GFP) [26,27]. In GUS transgenic plants, the presence of the reporter is visualized histochemically by introducing a chromogenic
glucuronide-based substrate (e.g. 4-methyl umbelliferyl glucuronide or 5-bromo-4-chloro-3-indolyl b-D-glucuronide). The substrate is introduced into the plant by abrading the underside of
the leaf by rubbing with a carborundum (silicon carbide) powder
and vacuum inﬁltration or by ﬁxing a section of the plant in formaldehyde and vacuum ﬁltration. In GFP transgenic plants the presence of the reporter is visualized directly under UV light as a green
color in contrast to the normal red color of the plant due to the
ﬂuorescence of chlorophyll. While both reporter constructs have
been used, the GFP reporter is commonly used because it is easily
visualized, it is generally less destructive than histochemistry, and
it allows the observer to follow gene expression over time. There-
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fore, this review of agroinﬁltration will focus on the use of GFP as a
reporter.
RNA silencing is initiated in the assay by introducing foreign
DNA into the transgenic plant by inﬁltrating a leaf with a tumor
causing plant bacterium called Agrobacterium tumefaciens. This
agrobacterium naturally carries a >200 kilobase tumor-inducing
(Ti) plasmid that is transferred to the plant and a segment of its
DNA called transfer-DNA (T-DNA) is integrated into the plant genome [28]. T-DNA can be modiﬁed so that a gene of interest can be
integrated into the plant. In addition to the T-DNA, the Ti plasmid
carries virulence genes (vir) responsible for transduction of the
plasmid into plant cells. However, the T-DNA and vir are not required to be on the same vector and in many instances a binary
system is used. The vir region is carried on a larger plasmid with
no T-DNA and is called the helper plasmid, and the T-DNA is carried on a smaller plasmid without vir and is called the binary plasmid. This smaller binary plasmid contains a more general origin of
replication used by both E. coli and A. tumefaciens that allows for
maintenance, cloning, and ampliﬁcation of the T-DNA in E. coli
[29,30]. In the agroinﬁltation RNA silencing assay, the GFP gene
is typically cloned into the T-DNA segment of this vector coupled
with the 35S promoter from the common plant virus Cauliﬂower
Mosaic Virus to promote heterologous expression of GFP [31].
A. tumefaciens containing a GFP construct is inﬁltrated into the
GFP transgenic plant and causes RNA silencing of the GFP transgene. The agrobacterium is grown in buffered Luria broth along
with acetosyringone which is naturally released during plant tissue
damage and recognized by the receptor encoded by the virA gene
[32]. The addition of acetosyringone has been shown to increase
the transformation rate of the Ti vector(s) [33]. Inﬁltration is facilitated by poking holes in the underside of the leaf with a razor
blade followed by injection of the agrobacterium with a needleless
syringe [34]. During the early post-inﬁltration period (2–3 days
post inﬁltration [dpi]) the transgenic plants exhibit a stronger
GFP expression against the weaker transient GFP expression as
indicated by a green color in and around the site of inﬁltration under UV light with a reddish-yellow boundary indicating initial
silencing of the GFP mRNA (Fig. 1A). Several days after inﬁltration
the GFP transgene silencing is observed in upper leaves and axillary shoots as indicated by a transition from green, through yellow
to a red color in these tissues under UV light [35]. In addition,
Northern blot analysis is performed to detect the presence of GFP
mRNA and conﬁrm the suppression of RNA silencing [36]. Given
enough time (14–21 dpi), RNA silencing spreads systemically
throughout producing a plant that appears completely red with little to no detectable GFP mRNA.
2.2. Co-inﬁltration assay to visualize and identify suppressors of RNA
silencing

Co-infiltration

~6 dpi

Fig. 1. Agroinﬁltration and coinﬁltration assays to visualize RNA silencing and
suppression of RNA silencing. (A) GFP transgenic plants were injected with an
agrobacterium containing a 35S-GFP inverted repeat construct. As the GFP mRNA is
silenced and the GFP subsides, the plant changes color from green to yellow to red
ﬂuorescence under UV light. The RNA silencing travels systemically through the
vascular system of the plant until the GFP is inhibited in the entire plant as 14–
21 days post-inoculation (dpi). (B) Wild-type plants were co-injected with an
agrobacterium containing a 35S-GFP inverted repeat construct and an agrobacterium containing a 35S-suppressor protein. The effects of RNA silencing are
suppressed allowing for the production of GFP mRNA and GFP. Suppression results
in green ﬂuorescence at the site of inoculation in the plant as visualized under UV
light. (C) Leaf of a wild-type N. benthamiana plant coinﬁltrated with an agrobacterium containing a 35S-GFP construct and an agrobacterium containing a 35SCarnation Italian Ringspot Virus p19 suppressor construct at 6 dpi (Reprinted from
Ref. [55], with permission from Elsevier).

Some viruses have the ability to reverse pre-existing GFP RNA
silencing in transgenic plants, but reversal of silencing is enhanced
with the expression of certain viral gene products that correlate
with the pathogenicity of the virus [5,37]. Other viruses require
the addition of certain virulence factor proteins to achieve suppression of pre-existing GFP RNA silencing [38–40]. Potato virus Y and
cucumber mosaic virus both encode suppressors of RNA silencing
(HC-Pro and 2b, respectively) that facilitate the reversal of a silenced GFP transgene. However, there is no suppression of transgenic GFP in potato virus X infected N. benthamiana.
Incorporation of the HC-Pro gene from potato virus Y or the 2b
gene of cucumber mosaic virus into the potato virus X genome
and expression of the gene products during infection results in
the suppression of GFP silencing. This was perhaps the ﬁrst observation of distinct mechanisms of RNA silencing suppression used
by different virulence factor proteins in different viruses and has

been implicated in the varying degrees of virulence in different
viruses. The identiﬁcation of these RNA silencing suppressors has
used a slightly modiﬁed form of the agroinﬁltration assay called
co-inﬁltration.
In the co-inﬁltration assay, two distinct agrobacterium cultures
carrying separate gene constructs are inﬁltrated into GFP transgenic plants or non-transgenic plants in equal issues at equal optical densities to initiate RNA silencing suppression [41–44]. The
ﬁrst agrobacterium is transformed with a 35S construct that contains GFP followed by an inverted repeat of GFP. The inverted repeat of GFP promotes dsRNA formation and serves as a substrate
for the DCLs to initiate RNA silencing of GFP upon plant co-inﬁltration. The second agrobacterium is transformed with a 35S-putative
suppressor protein construct that suppresses GFP RNA silencing.
The two cultures are co-inﬁltrated either simultaneously at the
same place on the leaf to suppress the local silencing of GFP or at
different locations on the same leaf to suppress the systemic
silencing of GFP by preventing the signal of silencing from moving
through the plant’s vascular system [45,46]. The concentration of
inﬁltrated cells is adjusted to avoid toxicity caused by the RNA
silencing suppressor protein interfering with the biochemical pathways of the plant. Visualization of RNA silencing suppression in
these assays is also done by observing GFP under UV illumination
and by GFP mRNA levels. In non-transgenic plants, the site of coinﬁltration displays a green ﬂuorescence under UV light against
the red background of the plant (Fig. 1B and C). In contrast, transgenic plants show a brighter green ﬂuorescence at the site of coinﬁltration against a weaker green background from the transiently expressed GFP transgene.
3. Suppressor protein afﬁnity and speciﬁcity for siRNA
A common approach used to measure the afﬁnity and speciﬁcity of suppressor protein interactions with siRNA is through equilibrium binding assays. In these experiments, an in vitro
equilibrium titration experiment is designed by adding samples
of puriﬁed suppressor protein and a labeled siRNA together. For direct binding experiments, samples of the suppressor protein at
varying concentration are added to labeled siRNA samples at a constant concentration. The concentration of the labeled siRNA is usually chosen to be 10-fold lower than the apparent dissociation
constant (Kd). Under these conditions, the concentration of the free
suppressor protein is nearly equivalent to the total suppressor protein under all conditions of the titration. These conditions are
achieved with high afﬁnity suppressors (i.e. low Kd values) using
a radioactive label like 32P, which provides high sensitivity in low
concentrations. The titration samples are allowed to reach equilibrium and the amount of bound and free siRNA or the fraction of
siRNA bound is measured. The fraction of bound, labeled siRNA
(h) is plotted versus free suppressor protein concentration, [P],
and the data are ﬁt to the hyperbolic equation.

h¼

½P
K d þ ½P

ð1Þ

to calculate an apparent Kd. Alternatively, if the labeled siRNA concentration is close to the Kd, then free suppressor protein is not
equal to the total suppressor protein. In this case the positive, physically realizable root of the quadratic equation is used.

h¼

qﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðPt þ Rt þ K d Þ ðPt þ Rt þ K d Þ2  4Pt Rt
2Rt

ð2Þ

where Pt is total suppressor protein concentration and Rt is total labeled siRNA concentration.
For competition binding experiments, samples of suppressor
protein at varying concentrations are added to a mixture of a la-

beled siRNA samples at a constant concentration and an unlabeled
competitor siRNA at varying concentrations. The fraction of bound,
labeled siRNA is plotted versus competitor siRNA concentration
using the equation.
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where Ct is total competitor siRNA concentration and Kc is the
apparent dissociation constant for the competitor siRNA [47,48].
In competition experiments, the value reported is usually the
apparent relative dissociation constant, Krel = Kc/Kd. The measurement of free and plant viral suppressor protein bound dsRNA/siRNA
or the fraction of bound dsRNA/siRNA to determine apparent Kd has
been performed with several methods including, but not limited to,
electrophoretic mobility shift assay (EMSA), isothermal titration
calorimetry (ITC), direct ﬂuorescence or ﬂuorescence polarization
(Fluorescence), surface plasmon resonance (SPR), and total internal
reﬂection ﬂuorescence spectroscopy (TIRFS) shown in Table 1.
3.1. Electrophoretic mobility shift assay
The most frequently used equilibrium binding assay to establish
suppressor protein afﬁnity for siRNA is the electrophoretic mobility shift assay. This assay allows for the measurement of free and
siRNA bound suppressor protein using gel electrophoresis to separate the two species. In addition to quantitatively measuring the
apparent Kd shown in Table 1, this method has been used as a qualitative diagnostic tool to determine if suppressor proteins bind siRNA [44,62]. The requirements of this assay are high concentrations
of puriﬁed protein and labeled siRNA.
Suppressor proteins are expressed and puriﬁed in bacterial
expression systems as glutathione S-transferase (GST) or histidine
fusion proteins separated by a protease site. The protein is puriﬁed
with afﬁnity chromatography using the fused tag. Hydrolysis of the
protein fusion with the associated protease is advantageous to prevent any inﬂuence with siRNA binding or the potential dimerization of the proteins, a common feature of the structurally
characterized suppressors [50,55,63]. Ion exchange and/or gel ﬁltration chromatography are used for puriﬁcation followed by centrifugal concentration to produce suppressor protein for binding
assays.
Milligram quantities of the individual strands of siRNA are
chemically synthesized and one of the two strands is labeled with
[c-32P] ATP and T4 polynucleotide kinase, annealed to the complementary strand, and puriﬁed by gel electrophoresis. For the kinase
reaction, 20–50 pmols of ssRNA with a free 50 hydroxyl group is
added to 0.3 lM [c-32P] ATP and 20 U of T4 polynucleotide kinase
in a Tris-buffered solution at pH 7.6. The reaction is incubated at
37 °C for 30 min, then it is incubated at 70 °C for 10 min to inactivate the kinase. A solution with equal molar concentration of the
complementary strand containing a 50 phosphate is added and
the strands are annealed in a thermocycler for 1 min. at 90 °C followed by slow cooling (1 °C/3 min.) until the strands reach 25 °C.
The slow cooling helps to minimize intra-strand base pairing and
hairpin formation. The annealed duplex is run on a non-denaturing
20% tris-borate-ethylenediaminetetraacetic acid (TBE) polyacrylamide gel using 1 TBE running buffer containing 18 mM Tris
Base, 18 mM boric acid, and 0.4 mM EDTA pH 8.3. The band containing the labeled siRNA is cut from the gel and placed in a solution of 0.5 M sodium acetate and 1 mM EDTA at pH 6.0 and left at
4 °C overnight to elute the RNA. The gel fragments are removed,
the labeled siRNA is precipitated with ethanol at 20 °C, and the
sample is lyophilized.

Table 1
dsRNA binding suppressor proteins encoded by plant viruses characterized by quantitative equilibrium binding assays.
Viral family

Virus

Suppressor Method

Refs.

Aureusvirus Pothos latent virus
Cucumovirus Cucumber mosaic virus
Tomato Aspermy virus

p14
2b
2b

Closterovirus Beet yellows virus
Hordeivirus Barley yellow mosaic virus
Poa semilatent hordeivirus
Pecluvirus
Peanut clump virus
Potyvirus
Tobacco etch virus
Potato virus Y
Turnip yellow virus
Cucumber vein yellowing virus
Tombusvirus Tomato bushy stunt virus
Cymbidium ringspot virus
Carnation Italian ringspot virus

P21
cB
cB
p15
HC-Pro
HC-Pro
HC-Pro
P1b
p19
p19
p19

[22]
[49]
[49]
[50]
[51]
[20,24]
[20]
[52]
[20]
[20,24]
[49]
[49]
[53,54]
[49]

Tenuivirus

NS3
NS3
p122
NSs

Rice hoja blanca virus
Rice stripe virus
Tobamovirus Tobacco mosaic virus
Tospovirus
Tomato spotted wilt virus, Ground nut ringspot virus, Impatiens necrotic spot virus,
Tomato yellow ring virus

The suppressor protein and siRNA titration samples are prepared, equilibrated, and run on a gel to separate bound and free
siRNA. For direct binding experiments, samples are prepared with
decreasing concentration of suppressor protein using serial dilution. Brieﬂy, an initial tube containing buffer, the highest concentration of suppressor protein, labeled siRNA, and water is
prepared, and half of this solution (for a twofold dilution) is diluted
in a tube containing an equal issue and concentration of buffer, labeled siRNA, and water only. Half of the issue of this new solution
(for a twofold dilution) is diluted in another tube with equal issue
and concentration of buffer, labeled siRNA, and water. The procedure is repeated until the concentration of the suppressor protein
is diluted to between one and two orders of magnitude below
the apparent Kd. The 1 tris-buffered saline binding buffer used
in these experiments contains Tris–HCl (20 mM), a reducing agent,
1 mM dithiothreitol (DTT), b-mercaptoethanol (BME), or tris(2-carboxyethyl) phosphine (TCEP) if it is used in the puriﬁcation of the
suppressor protein without chelators (e.g. EDTA) [64], and a low
concentration of a surfactant, usually 0.01–0.02% Tween-20 to
block non-speciﬁc binding of protein/siRNA to the pipette tips
and microcentrifuge tubes. For competition binding experiments,
the constant concentration of suppressor protein is chosen to give
80–90% bound siRNA based on the direct binding experiments. The
labeled siRNA at constant concentration is added simultaneously
with decreasing concentrations of the unlabeled siRNA. Brieﬂy,
an initial tube containing buffer, suppressor protein, the highest
concentration of competitor siRNA, labeled siRNA, and water is
prepared, and half of this solution (for a twofold dilution) is diluted
in a tube containing an equal issue and concentration of buffer,
suppressor protein, labeled siRNA, and water only. Half of the issue
of this new solution (for a twofold dilution) is diluted in another
tube with equal issue and concentration of buffer, suppressor protein, labeled siRNA and water. The samples from both direct and
competition binding experiments are equilibrated at room temperature for one hour and the samples are adjusted to a ﬁnal concentration of 7.5% (w/v) with Ficoll 400. Samples are loaded onto a
running 6% TBE polyacrylamide gel in 0.5 TBE running buffer. A
blank lane containing buffered Ficoll 400 and bromophenol blue
is used to monitor the progress of the gel. The siRNA bound to suppressor protein moves through the gel slower and will be shifted
relative to the unbound siRNA.

EMSA
EMSA/SPR
SPR
ITC
TIRFS
EMSA
EMSA
EMSA
EMSA
EMSA
SPR
SPR
EMSA
EMSA/SPR
EMSA
EMSA
Fluorescence
EMSA
EMSA
EMSA
EMSA

[24,55]
[56,57]
[58]
[59]
[60]
[61]

The gel is dried and exposed to a storage phosphor screen followed by imaging of the screen and quantiﬁcation of the free and
bound siRNA bands. After the gels are dried, they are exposed to
the phosphor screen for 1–5 days depending on the amount of labeled siRNA used. For high afﬁnity interactions with low apparent
Kd, the concentration of the labeled siRNA is low and requires longer exposure to the phosphor. The phosphor screens are imaged
with photostimulated luminescence, the bands associated with
bound and free siRNA are quantiﬁed by integrating the band intensities, and the data are ﬁt to the appropriate equation for equilibrium binding conditions [65].
The electrophoretic mobility shift assay is perhaps the most commonly used technique especially for its sensitivity, but there are several disadvantages. The assay requires a separation of bound and
free siRNA during gel electrophoresis which disrupts the equilibrium binding conditions. This disruption is most apparent where
the binding afﬁnity between siRNA and suppressor protein is low.
In addition, the equilibrated samples are either added to electrophoresis loading buffer usually containing TBE and Ficoll 400 and run in
0.5 TBE thereby disrupting equilibrium, or the samples are allowed
to equilibrate in the gel-loading buffer and run in 0.5 TBE. In both
conditions, the equilibrium buffer conditions are dictated to some
extent by the method rather than experimenter.
3.2. Fluorescence polarization
Spectroscopic equilibrium binding assays like ﬂuorescence
polarization measure siRNA species while still in equilibrium
rather than separating bound and free siRNA and allow for ﬂexibility in the conditions of the binding solution. In ﬂuorescence polarization experiments, the fraction of free and suppressor bound
ﬂuorescently labeled siRNA is measured indirectly based on their
different tumbling properties in solution. The ﬂuorophore is excited with vertically polarized light and the intensity of both vertically and horizontally polarized emitted light is measured to
determine the amount of depolarization caused by tumbling or
molecular rotation in solution during the ﬂuorescence lifetime.
Polarization is calculated as

P¼

IVV  GIVH
IVV þ GIVH

ð4Þ

A

or with respect to competitor siRNA concentration in competition
binding experiments and ﬁt to the appropriate equation for equilibrium binding conditions.
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Fig. 2. Fluorescence polarization of siRNA and siRNA:suppressor protein complex.
(A) Free siRNA (white) is excited with vertically polarized light and rotates during
the ﬂuorescence lifetime causing the emitted light to be largely depolarized and
resulting in an IVH and IVV that are similar in magnitude. (B) Suppressor protein
(blue and green dimer) bound siRNA (white) is excited with vertically polarized
light, but rotation of the larger complex is slow relative to the ﬂuorescence lifetime
allowing the emitted light to stay largely polarized resulting in a greater IVV relative
to IVH as compared to free siRNA.

where IVV and IVH are the vertically and horizontally polarized intensities of emitted light when excited with vertically polarized light,
and G, the grating correction factor, is the ratio of the vertically to
horizontally polarized emitted light when excited with horizontally
polarized light (G = IHV/IHH). The grating correction factor is instrument dependent and corrects for differences in the detection of vertically and horizontally polarized light [66,67]. In these
experiments, a ﬂuorophore-labeled siRNA is excited by polarized
light, and the emitted light will be depolarized due to molecular
rotation of the siRNA during the ﬂuorescence lifetime (Fig. 2A). In
contrast, when the labeled siRNA is bound to the suppressor protein
and is excited by polarized light, the emitted light will remain relatively polarized due to the slower molecular rotation of the larger
complex (Fig. 2B).
The ﬂuorophore label is chosen and attached to the ssRNA during chemical synthesis. Two common ﬂuorophores that have been
incorporated into phosphoramidites for RNA synthesis are Cy3 and
Dy547. Both are based on cyanine dyes and have similar excitation
(550 nm) and emission (570 nm) maxima [68]. One of the RNA
strands composing the double-stranded siRNA is chemically synthesized with the ﬂuorophore attached at the 50 end. Since the label could interfere with binding, it is necessary to perform a
competition experiment with a standard, unlabeled siRNA (e.g.
19-bp, 2 nucleotide 30 overhangs, and 50 phosphates) as a control.
siRNA annealing and preparation of equilibrated samples are performed in the same manner as in the electrophoretic mobility shift
assay for both direct and competition binding experiments. Fluorescence polarization is measured at room temperature in a ﬂuorometer with manual or automated large aperture polarizers for
emission and excitation. Polarization is plotted with respect to
suppressor protein concentration in direct binding experiments

The identiﬁcation of many RNA silencing suppressor proteins
with the agroinﬁltration assay has further elucidated the mechanism of the associated viral infections. Virulence of several plant
viruses has been directly linked to the expression of a suppressor
protein. As a result, it has been shown that artiﬁcial microRNAs
(miRNAs) produced by transgenic plants targeting a viral suppressor can serve as a counter–counter defense strategy to provide
plants with virus-speciﬁc resistance [69]. In addition, small molecule inhibitors of silencing suppressors have been identiﬁed which
could be adapted to be used as anti-viral agents [57].
The characterization of the speciﬁcity of these suppressors for
different dsRNA including siRNA and miRNA using equilibrium
binding experiments has laid the groundwork for their use as biomolecular tools. The p19 viral silencing suppressor has been used
to study organism development and RNA silencing in heterologous
systems [21]. During development, miRNAs with various unpaired
or mismatched bases are transcribed by an organism and have
been shown to control gene expression. Transgenic expression of
p19 results in binding and sequestration of miRNAs controlling
that portion of organism development that is dependent on RNA
silencing regulated gene expression. As an extension of p19’s ability to bind to miRNAs, it has been used to both sequester and
immunoprecipate miRNAs in vivo [70,71], and it has been used to
bind and quantify miRNAs in blood serum using afﬁnity chromatography [72].
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